CHHHF Stock Chart & Stats
$2.42
-$0.09(-3.53%)
At close: 4:00 PM EDT
$2.42
-$0.09(-3.53%)
Day’s Range― - ―
52-Week Range$2.01 - $2.89
Previous CloseN/A
Volume10.10K
Average Volume (3M)N/A
Market Cap
$154.34M
Enterprise Value$304.96
Total Cash (Recent Filing)$15.32M
Total Debt (Recent Filing)$78.13M
Price to Earnings (P/E)7.9
Beta0.05
Next Earnings
Nov 11, 2026EPS Estimate
0.02Next Dividend Ex-DateN/A
Dividend Yield2.34%
Share Statistics
EPS (TTM)0.43
Shares Outstanding63,453,266
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)2.19
Price to Sales (P/S)0.65
P/FCF Ratio10.92
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit<0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price Target
$3.74Price Target Upside54.42% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
EPS Forecast (FY)0.1
Revenue Forecast (FY)$272.88M
Bulls Say, Bears Say
Bulls Say
Strong Free Cash Flow And ConversionRobust FCF (~$23.5M TTM) with ~84% conversion from net income indicates durable earnings quality and cash generation. That cash convertibility supports debt paydown, modest dividends and reinvestment in centralized dispensing and IT, sustaining operational improvements over coming quarters.
Material Contracted Bed Growth (3,000-bed Win)The long-term national contract to add ~3,000 beds meaningfully strengthens recurring prescription volumes and revenue visibility. Higher utilization of centralized logistics should drive operational leverage and accretive EBITDA as onboarding completes and stabilizes volumes over the medium term.
Improving Leverage And Shareholder ReturnsDebt metrics have improved and management resumed modest payouts, evidenced by a 10% dividend increase. This combination signals balance-sheet repair and disciplined capital allocation, giving the company greater flexibility to fund organic bed additions and absorb operational shocks.
Bears Say
Provincial Funding Change In Ontario (~$2.0M Impact)The Ontario ward-bed funding change is a structural provincial policy shift that reduces durable revenue and margins until affected rooms are redeveloped. Recovery depends on third-party redevelopment timelines, leaving a multi-year revenue and cash-flow headwind through at least late 2027.
Uneven Multi-year Revenue GrowthTop-line inconsistency — flat revenue in 2025 following earlier declines — limits sustainable operating leverage from centralized dispensing. Without consistent organic bed growth or recurring payer improvements, margin progress depends heavily on successful onboarding of new contracts.
Meaningful Gross Debt And Near-term Liquidity PressureAlthough leverage has improved, ~ $78M of gross debt and recent QoQ cash declines constrain flexibility. Elevated debt exposes the company to funding risk if policy or onboarding setbacks occur, potentially limiting capacity for opportunistic M&A or faster bed-network expansion.
CareRx News
CHHHF FAQ
What was CareRx’s price range in the past 12 months?
CareRx lowest stock price was $2.01 and its highest was $2.89 in the past 12 months.
What is CareRx’s market cap?
CareRx’s market cap is $154.34M.
When is CareRx’s upcoming earnings report date?
CareRx’s upcoming earnings report date is Nov 11, 2026 which is in 103 days.
How were CareRx’s earnings last quarter?
CareRx released its earnings results on Jul 29, 2026. The company reported $0.007 earnings per share for the quarter, missing the consensus estimate of $0.016 by -$0.009.
Is CareRx overvalued?
According to Wall Street analysts CareRx’s price is currently Undervalued.
Does CareRx pay dividends?
CareRx pays a Quarterly dividend of $0.016 which represents an annual dividend yield of 2.34%. See more information on CareRx dividends here
What is CareRx’s EPS estimate?
CareRx’s EPS estimate is 0.02.
How many shares outstanding does CareRx have?
CareRx has 63,453,266 shares outstanding.
What happened to CareRx’s price movement after its last earnings report?
CareRx reported an EPS of $0.007 in its last earnings report, missing expectations of $0.016. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of CareRx?
Currently, no hedge funds are holding shares in CHHHF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CareRx Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$3.74 (54.42% Upside)
$3.74 (54.42% Upside)
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
86.26%
12-Months-Change
Fundamentals
Return on Equity
2.34%
Trailing 12-Months
Asset Growth
11.32%
Trailing 12-Months
Company Description
CareRx
CareRx Corporation, operating with its subsidiaries, specializes in delivering tailored pharmaceutical services to Canada's senior demographic. The company manages a vast network of medication dispensing facilities, which are responsible for providing chronic prescriptions and a variety of other advanced clinical pharmacy solutions. Currently, it caters to approximately 50,000 individuals residing in roughly 900 distinct senior and communal living environments, including extended care residences, retirement communities, supportive living facilities, and group homes. Founded in 2001 and based in Toronto, Canada, the corporation rebranded as CareRx Corporation in June 2020, having formerly been known as Centric Health Corporation.
CHHHF Stock 12 Month Forecast
Average Price Target
$3.74
▲(54.42% Upside)
Extendicare
―
Nova Leap Health
―
Sienna Senior Living
―
Medical Facilities
―
WELL Health Technologies Corp
―